|
UBAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.263700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.171710E-02 |
| Normal-vs-Stage2 |
1.276780E-01 |
| Normal-vs-Stage3 |
9.335800E-01 |
| Normal-vs-Stage4 |
9.832000E-01 |
| Stage1-vs-Stage2 |
8.374600E-01 |
| Stage1-vs-Stage3 |
8.840100E-02 |
| Stage1-vs-Stage4 |
3.039000E-01 |
| Stage2-vs-Stage3 |
2.716400E-01 |
| Stage2-vs-Stage4 |
4.291400E-01 |
| Stage3-vs-Stage4 |
9.459800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.800100E-02 |
| Normal-vs-AfricanAmerican |
1.869770E-01 |
| Normal-vs-Asian |
6.496400E-01 |
| Caucasian-vs-AfricanAmerican |
7.837200E-01 |
| Caucasian-vs-Asian |
9.539600E-01 |
| AfricanAmerican-vs-Asian |
8.664000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.613610E-02 |
| Normal-vs-Female |
7.914600E-01 |
| Male-vs-Female |
5.881500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.496100E-02 |
| Normal-vs-Extreme_Weight |
1.899970E-02 |
| Normal-vs-Obese |
6.447200E-01 |
| Normal-vs-Extreme_Obese |
4.466100E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.419800E-01 |
| Normal_Weight-vs-Obese |
2.818200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.344600E-01 |
| Extreme_Weight-vs-Obese |
1.652970E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.098200E-01 |
| Obese-vs-Extreme_Obese |
3.431200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.674800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.982400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.861200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.429370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.781600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.992100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.984800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.383800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.791000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.606400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.518000E-02 |
| Normal-VS-Type2 PRCC |
3.931600E-02 |
| Normal-VS-KIRP CIMP |
9.724900E-03 |
| Normal-VS-Unclassified PRCC |
1.618210E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.484200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.12800000012992E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
9.078600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.61438999999319E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
7.546000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.85760000000524E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.119100E-03 |
| Normal-vs-N1 |
4.875600E-01 |
| Normal-vs-N2 |
1.427850E-02 |
| N0-vs-N1 |
5.114400E-02 |
| N0-vs-N2 |
3.750600E-01 |
| N1-vs-N2 |
2.049600E-01 |
|
|
